246 related articles for article (PubMed ID: 26453335)
21. Effect of muscle length on cross-bridge kinetics in intact cardiac trabeculae at body temperature.
Milani-Nejad N; Xu Y; Davis JP; Campbell KS; Janssen PM
J Gen Physiol; 2013 Jan; 141(1):133-9. PubMed ID: 23277479
[TBL] [Abstract][Full Text] [Related]
22. Hypothermia elongates the contraction-relaxation cycle in explanted human failing heart decreasing the time for ventricular filling during diastole.
Hiis HG; Cosson MV; Dahl CP; Fiane AE; Levy FO; Andersen GØ; Krobert KA
Am J Physiol Heart Circ Physiol; 2018 Nov; 315(5):H1137-H1147. PubMed ID: 30004809
[TBL] [Abstract][Full Text] [Related]
23. Heart failure switches the RV alpha1-adrenergic inotropic response from negative to positive.
Wang GY; Yeh CC; Jensen BC; Mann MJ; Simpson PC; Baker AJ
Am J Physiol Heart Circ Physiol; 2010 Mar; 298(3):H913-20. PubMed ID: 20035030
[TBL] [Abstract][Full Text] [Related]
24. Altered myocardial force-frequency relation in human heart failure.
Mulieri LA; Hasenfuss G; Leavitt B; Allen PD; Alpert NR
Circulation; 1992 May; 85(5):1743-50. PubMed ID: 1572031
[TBL] [Abstract][Full Text] [Related]
25. Beta-adrenergic neuroeffector abnormalities in the failing human heart are produced by local rather than systemic mechanisms.
Bristow MR; Minobe W; Rasmussen R; Larrabee P; Skerl L; Klein JW; Anderson FL; Murray J; Mestroni L; Karwande SV
J Clin Invest; 1992 Mar; 89(3):803-15. PubMed ID: 1311717
[TBL] [Abstract][Full Text] [Related]
26. Direct inotropic effects of exogenous and endogenous urotensin-II: divergent actions in failing and nonfailing human myocardium.
Quaile MP; Kubo H; Kimbrough CL; Douglas SA; Margulies KB
Circ Heart Fail; 2009 Jan; 2(1):39-46. PubMed ID: 19808314
[TBL] [Abstract][Full Text] [Related]
27. Reduced alpha 1- and beta 2-adrenoceptor-mediated positive inotropic effects in human end-stage heart failure.
Steinfath M; Danielsen W; von der Leyen H; Mende U; Meyer W; Neumann J; Nose M; Reich T; Schmitz W; Scholz H
Br J Pharmacol; 1992 Feb; 105(2):463-9. PubMed ID: 1348446
[TBL] [Abstract][Full Text] [Related]
28. Positive inotropic effects of the novel Na+-channel modulator BDF 9198 in human nonfailing and failing myocardium.
Müller-Ehmsen J; Brixius K; Schwinger RH
J Cardiovasc Pharmacol; 1998 May; 31(5):684-9. PubMed ID: 9593067
[TBL] [Abstract][Full Text] [Related]
29. The cross-bridge dynamics is determined by two length-independent kinetics: Implications on muscle economy and Frank-Starling Law.
Amiad Pavlov D; Landesberg A
J Mol Cell Cardiol; 2016 Jan; 90():94-101. PubMed ID: 26654781
[TBL] [Abstract][Full Text] [Related]
30. The effects of propofol on the contractility of failing and nonfailing human heart muscles.
Sprung J; Ogletree-Hughes ML; McConnell BK; Zakhary DR; Smolsky SM; Moravec CS
Anesth Analg; 2001 Sep; 93(3):550-9. PubMed ID: 11524317
[TBL] [Abstract][Full Text] [Related]
31. Cross-bridge dynamics in human ventricular myocardium. Regulation of contractility in the failing heart.
Hajjar RJ; Gwathmey JK
Circulation; 1992 Dec; 86(6):1819-26. PubMed ID: 1451254
[TBL] [Abstract][Full Text] [Related]
32. Selective downregulation of the angiotensin II AT1-receptor subtype in failing human ventricular myocardium.
Asano K; Dutcher DL; Port JD; Minobe WA; Tremmel KD; Roden RL; Bohlmeyer TJ; Bush EW; Jenkin MJ; Abraham WT; Raynolds MV; Zisman LS; Perryman MB; Bristow MR
Circulation; 1997 Mar; 95(5):1193-200. PubMed ID: 9054849
[TBL] [Abstract][Full Text] [Related]
33. Calcium cycling proteins and force-frequency relationship in heart failure.
Hasenfuss G; Reinecke H; Studer R; Pieske B; Meyer M; Drexler H; Just H
Basic Res Cardiol; 1996; 91 Suppl 2():17-22. PubMed ID: 8957539
[TBL] [Abstract][Full Text] [Related]
34. Energetics of calcium cycling in nonfailing and failing human myocardium.
Hasenfuss G; Mulieri LA; Holubarsch C; Pieske B; Just H; Alpert NR
Basic Res Cardiol; 1992; 87 Suppl 2():81-92. PubMed ID: 1299212
[TBL] [Abstract][Full Text] [Related]
35. Ca2+ handling and sarcoplasmic reticulum Ca2+ content in isolated failing and nonfailing human myocardium.
Pieske B; Maier LS; Bers DM; Hasenfuss G
Circ Res; 1999 Jul; 85(1):38-46. PubMed ID: 10400909
[TBL] [Abstract][Full Text] [Related]
36. Myocardial region (right or left ventricle) and aetiology of heart failure can influence the inotropic effect of ouabain in failing human myocardium.
Padrini R; Panfili M; Magnolfi G; Piovan D; Casarotto D; Ferrari M
Br J Clin Pharmacol; 1999 Nov; 48(5):743-9. PubMed ID: 10594477
[TBL] [Abstract][Full Text] [Related]
37. Reduced length-dependent cross-bridge recruitment in skinned fiber preparations of human failing myocardium.
Brixius K; Savidou-Zaroti P; Bloch W; Schwinger RH
Eur J Appl Physiol; 2003 May; 89(3-4):249-56. PubMed ID: 12736832
[TBL] [Abstract][Full Text] [Related]
38. Upregulation of beta(3)-adrenoceptors and altered contractile response to inotropic amines in human failing myocardium.
Moniotte S; Kobzik L; Feron O; Trochu JN; Gauthier C; Balligand JL
Circulation; 2001 Mar; 103(12):1649-55. PubMed ID: 11273992
[TBL] [Abstract][Full Text] [Related]
39. The length-dependent activation of contraction is equally impaired in impuberal male and female rats in monocrotaline-induced right ventricular failure.
Lookin O; Balakin A; Kuznetsov D; Protsenko Y
Clin Exp Pharmacol Physiol; 2015 Nov; 42(11):1198-206. PubMed ID: 26234534
[TBL] [Abstract][Full Text] [Related]
40. Fibrosis-Related Gene Expression in Single Ventricle Heart Disease.
Nakano SJ; Siomos AK; Garcia AM; Nguyen H; SooHoo M; Galambos C; Nunley K; Stauffer BL; Sucharov CC; Miyamoto SD
J Pediatr; 2017 Dec; 191():82-90.e2. PubMed ID: 29050751
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
